PSP Research »

Amylyx Pharmaceuticals shares owned by PSP Research

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $151k 11k 13.90
2025-12-31 $534k 44k 12.08

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
TCG Crossover Management
Vanguard Group
Commodore Capital
Henderson Group
Saturn V Capital Management
Vanguard Capital Management
First Light Asset Management
Driehaus Capital Management
Adage Capital Partners GP
Goldman Sachs Group
Franklin Resources
Geode Capital Management

View all funds holding Amylyx Pharmaceuticals